DORAMA-NEO (naphazoline hydrochloride) Eye wash, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceuticals CO., LTD. 1-5-27 Motoakasaka Minato-Ku Tokyo, Japan, NDC 49873-020-01
Published May 31, 2017 · Recall initiated: February 16, 2017
Summary
FDA records drug Class II recall D-0856-2017, published May 31, 2017 and initiated February 16, 2017. Recalling firm: Sato Pharmaceutical Inc.; Status: Terminated; Reported quantity: 14,325 bottles; Lot: Lot #: WXTZ, Exp. Sep 2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Sato Pharmaceutical Inc.
- Distributor
- US: Hawaii, Guam, Saipan, SPI
- Lot
- Lot #: WXTZ, Exp. Sep 2019
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAYunker(branded) Energy & Health Herbal Supplement with Vitamins; Manufactured by Sato Pharmaceuticals Co.June 10, 2026
- FDAWAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (NDC 0363-1407-01, UPC 3November 20, 2019
- FDAMotion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC.November 20, 2019
- FDAMotion Sickness Strips (meclizine hydrochloride) 25 mg strips, 8-count box, Distributed by Sato PharmaceuticalNovember 20, 2019
- FDASATO CLEAR (naphazoline hydrochloride) Redness Reliever Eye Drops, packaged in 0.5 FL OZ (15mL) bottles,May 31, 2017
- FDAChildren's Cetirizine Hydrochloride Chewable Tablets, 5 mg, 30-count bottle, Manufactured by: SunMay 31, 2017
Questions about this recall
Was DORAMA-NEO (naphazoline hydrochloride) Eye wash, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceuticals CO., LTD. 1-5-27 Motoakasaka Minato-Ku Tokyo, Japan, NDC 49873-020-01 recalled?
Yes. FDA published recall D-0856-2017 on May 31, 2017. Reported hazard: Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.
What should I do if I have this product?
Voluntary: Firm initiated · Letter